Avid Bioservices

HQ
Tustin
343 Total Employees
Year Founded: 2002

Jobs at Avid Bioservices

Let Your Resume Do The Work
Upload your resume to be matched with jobs you're a great fit for.

5 Days AgoSaved
Remote
United States
Healthtech • Pharmaceutical
Leads strategic and key account management for major pharmaceutical and biotechnology customers. Develops multi-year account plans, expands customer relationships and share of wallet, identifies new biologics development and manufacturing opportunities, and drives enterprise partnerships. Builds executive-level relationships, leads business reviews, coordinates cross-functional teams, manages account risks, and provides leadership with customer, pipeline, competitive, and growth insights.
12 Days AgoSaved
Remote
United States
Healthtech • Pharmaceutical
Leads European business development for a biologics CDMO, driving new sales, revenue, pipeline growth, and client partnerships. Manages opportunities from prospecting through contract negotiation, develops sales strategies, maintains existing accounts, coordinates proposals and pricing, and collaborates with technical, operations, legal, finance, and program management teams. Represents the company at industry conferences and manages client visits and audits. Requires deep knowledge of biologics development, manufacturing, regulatory requirements, and pharmaceutical contracting.
12 Days AgoSaved
Remote
United States
Healthtech • Pharmaceutical
Leads business development and sales growth for biologics development and manufacturing services in Japan. Identifies, develops, and closes opportunities with biotechnology, biopharmaceutical, and pharmaceutical clients; manages negotiations, proposals, contracts, and client relationships. Partners with technical, operations, legal, finance, and program management teams, represents the company at industry conferences, coordinates client visits and audits, and maintains CRM opportunity records. Requires substantial CDMO sales experience and strong knowledge of biologics development, manufacturing, technology transfer, regulatory requirements, and monoclonal antibodies.